-
to decipher the regulatory code controlling gene expression in plants through the engineering and large-scale validation of synthetic promoters. Within the ERC-funded multiCODE project, we aim
-
this specificity and test how these regulate structure and function of higher-order thalamocortical inputs in cortical circuits. The applicant will use various technologies, including super-resolution imaging
-
: In vitro and/or in vivo phage display; Cloning, engineering, expression, purification and characterization of VHHs. We invite applications from dynamic individuals with a strong drive for innovation
-
biopharmaceuticals. The research at CMB pushes the boundaries of biomolecular and bioinformatics research and engineering technologies. VIB.AI studies fundamental problems in biology by combining machine learning with
-
investigating sensory signaling in the bladder wall and its role in lower urinary tract disorders (LUTd). The project involves advanced techniques such as ex vivo calcium imaging of mouse and human urothelium, X
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based
-
and ultimately accelerate these activities to combat climate change. Our approach combines science and engineering, beginning with the study of fundamental microbial metabolic processes that can be
-
, CS, Bio-engineering, or Bioinformatics. You have experience with applying AI technologies in (regulatory) genomics, as demonstrated by peer-reviewed publications in international journals. Having good
-
Overview The group of Specialized Metabolism , led by Prof. Alain Goossens at the VIB-UGent Center for Plant Systems Biology, and the metabolic engineering research group, led by Prof. Marjan De Mey
-
brain xenotransplantation, mouse transgenesis, in vivo mouse brain imaging, and ex vivo human brain recordings. See more in selected references from the lab: Libé-Philippot et at al. Cell (2023) 186(26